Prior reports suggested that high Ki-67 index, positive p53 expression, and loss of p16 represent typical characteristics for invasive breast cancer and are promising biomarkers for DCIS progression [35]–[38]. The gene discussed is MKI67; the disease is ductal breast carcinoma in situ.